Bard Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,125
Closed -$418K 297
2022
Q2
$418K Hold
6,125
0.04% 207
2022
Q1
$537K Sell
6,125
-375
-6% -$32.5K 0.04% 186
2021
Q4
$569K Hold
6,500
0.05% 179
2021
Q3
$532K Hold
6,500
0.05% 181
2021
Q2
$593K Hold
6,500
0.05% 175
2021
Q1
$556K Sell
6,500
-180
-3% -$16.2K 0.05% 170
2020
Q4
$631K Buy
+6,680
New +$584K 0.06% 165

Other funds holding NVS

Bard Financial Services's NVS Position: Q3 2022 in Review

Bard Financial Services sold out of Novartis (NVS) in Q3 2022, closing a stake of 6,125 shares — an estimated $418K sold.

Bard Financial Services first reported a position in NVS in Q4 2020 and held it in 7 quarters. The position peaked at $631K in Q4 2020. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • Bard Financial Services reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
  • Bard Financial Services sold 6,125 Novartis shares in Q3 2022, an estimated $418K.
  • Bard Financial Services first reported a position in Novartis in Q4 2020 and held it in 7 quarters.
  • Bard Financial Services's Novartis position peaked at $631K in Q4 2020.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Bard Financial Services's 13F filing for Q3 2022, filed 26 Oct 2022.